c-di-GMP protects against intranasal Acinetobacter baumannii infection in mice by chemokine induction and enhanced neutrophil recruitment
Authors:
- Rhonda KuoLeeRKRhonda KuoLee
- Greg HarrisGHGreg Harris
- Kha TramKTKha Tram
- Hongbin YanHYHongbin Yan
- Wangxue ChenWCWangxue Chen
- 1 September 2011
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 11 (9) , 1378-1383
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- National Research Council Canada
This publication has 29 references indexed in Scilit:
- 3′,5′-Cyclic diguanylic acid: a small nucleotide that makes big impactsChemical Society Reviews, 2010
- Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMPBioorganic & Medicinal Chemistry Letters, 2008
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007
- Nosocomial Acinetobacter pneumoniaRespirology, 2007
- Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcomeClinical Microbiology and Infection, 2007
- The Epidemiology and Control of Acinetobacter baumannii in Health Care FacilitiesClinical Infectious Diseases, 2006
- Clinical impact and pathogenicity of AcinetobacterClinical Microbiology and Infection, 2005
- Overview of Nosocomial Infections Caused by Gram-Negative BacilliClinical Infectious Diseases, 2005
- C‐di‐GMP: the dawning of a novel bacterial signalling systemMolecular Microbiology, 2005
- Cyclic diguanylate (c‐di‐GMP) regulates Vibrio cholerae biofilm formationMolecular Microbiology, 2004